
|Articles|August 1, 2003
Advances in Biotherapy: The Pivotal Role of TNF Inhibition in Psoriatic Arthritis and Psoriasis (PDF)
A CME monograph sponsored by The Institute for Medical Studies and Advanstar Healthcare Communications. Supported by an unrestricted educational grant from Amgen Inc. and Wyeth Pharmaceuticals.The views and opinions expressed are those of the interviewed physicians and do not necessarily reflect the views of the editors, Advanstar Healthcare Communications. The Institute of Medical Studies, Amgen Inc., or Wyeth Pharmaceuticals. For faculty, and learning objectives please download this PDF file.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











